Dimensional Fund Advisors LP Has $688,000 Position in Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

Dimensional Fund Advisors LP increased its stake in shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOXFree Report) by 9.5% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 61,330 shares of the company’s stock after buying an additional 5,341 shares during the quarter. Dimensional Fund Advisors LP owned about 0.10% of Bioceres Crop Solutions worth $688,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the stock. Wellington Management Group LLP lifted its stake in Bioceres Crop Solutions by 3.1% during the fourth quarter. Wellington Management Group LLP now owns 236,906 shares of the company’s stock worth $3,253,000 after purchasing an additional 7,096 shares during the last quarter. Fourth Sail Capital LP lifted its stake in Bioceres Crop Solutions by 136.1% during the first quarter. Fourth Sail Capital LP now owns 1,627,630 shares of the company’s stock worth $20,606,000 after purchasing an additional 938,282 shares during the last quarter. Oppenheimer & Co. Inc. bought a new stake in Bioceres Crop Solutions during the first quarter worth $139,000. Lazard Asset Management LLC bought a new stake in Bioceres Crop Solutions during the first quarter worth $212,000. Finally, Sumitomo Mitsui Trust Holdings Inc. bought a new stake in Bioceres Crop Solutions during the second quarter worth $472,000. Institutional investors and hedge funds own 17.68% of the company’s stock.

Wall Street Analysts Forecast Growth

BIOX has been the subject of several recent analyst reports. Lake Street Capital cut their target price on Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating for the company in a research note on Wednesday, September 11th. Roth Capital upgraded Bioceres Crop Solutions to a “strong-buy” rating in a research note on Tuesday, July 2nd. Canaccord Genuity Group dropped their price target on Bioceres Crop Solutions from $17.00 to $12.50 and set a “buy” rating for the company in a research note on Wednesday, September 11th. Canaccord Genuity Group upgraded Bioceres Crop Solutions to a “strong-buy” rating in a research note on Friday, July 19th. Finally, Oppenheimer dropped their price target on Bioceres Crop Solutions from $17.00 to $16.00 and set an “outperform” rating for the company in a research note on Wednesday, September 11th. Four equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, Bioceres Crop Solutions presently has a consensus rating of “Buy” and a consensus target price of $13.63.

Get Our Latest Analysis on Bioceres Crop Solutions

Bioceres Crop Solutions Stock Up 0.8 %

Shares of NASDAQ:BIOX opened at $7.51 on Monday. The firm has a market cap of $471.61 million, a P/E ratio of 751.00 and a beta of 0.47. The company has a quick ratio of 0.91, a current ratio of 1.28 and a debt-to-equity ratio of 0.35. Bioceres Crop Solutions Corp. has a 12-month low of $7.35 and a 12-month high of $14.05. The business has a fifty day simple moving average of $9.19 and a 200 day simple moving average of $10.70.

Bioceres Crop Solutions (NASDAQ:BIOXGet Free Report) last announced its earnings results on Monday, September 9th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.20 by ($0.23). The company had revenue of $124.30 million for the quarter, compared to the consensus estimate of $126.75 million. Bioceres Crop Solutions had a return on equity of 0.93% and a net margin of 0.68%. During the same period in the prior year, the business earned ($0.06) earnings per share. Analysts predict that Bioceres Crop Solutions Corp. will post 0.39 earnings per share for the current year.

Bioceres Crop Solutions Profile

(Free Report)

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.

Featured Articles

Want to see what other hedge funds are holding BIOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bioceres Crop Solutions Corp. (NASDAQ:BIOXFree Report).

Institutional Ownership by Quarter for Bioceres Crop Solutions (NASDAQ:BIOX)

Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.